175 related articles for article (PubMed ID: 35013091)
1. A Well-Differentiated Grade-3 Neuroendocrine Tumor in the Ascending Colon: A Case Report.
AlSaffar A; Wood S; AlRabiy F; Hamie D; Termos S
Am J Case Rep; 2022 Jan; 23():e933792. PubMed ID: 35013091
[TBL] [Abstract][Full Text] [Related]
2. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
Tang LH; Basturk O; Sue JJ; Klimstra DS
Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
[TBL] [Abstract][Full Text] [Related]
3. Highly aggressive neuroendocrine neoplasm of the ascending colon: a wolf in sheep's clothing.
Keelan S; Bogle M; Gurung B; Dorfman G
Ann R Coll Surg Engl; 2022 Apr; 104(4):e98-e101. PubMed ID: 34825841
[TBL] [Abstract][Full Text] [Related]
4. Concurrent large cell neuroendocrine carcinoma and adenocarcinoma of the ascending colon: a case report.
Kim YN; Park HS; Jang KY; Moon WS; Lee DG; Lee H; Lee MR; Kim KR
J Korean Soc Coloproctol; 2011 Jun; 27(3):157-61. PubMed ID: 21829772
[TBL] [Abstract][Full Text] [Related]
5. Coexisting tubular adenoma with a neuroendocrine carcinoma of colon allowing early surgical intervention and implicating a shared stem cell origin.
Soliman ML; Tiwari A; Zhao Q
World J Gastroenterol; 2017 Feb; 23(6):1106-1112. PubMed ID: 28246485
[TBL] [Abstract][Full Text] [Related]
6. Mixed neuroendocrine-non-neuroendocrine neoplasms of the right colon: a case report.
Barkaoui ZE; Najih M; Mehdi AE; Majdoubi HE; Messaoudi IE; Essaoudi MA; Bouzroud M; Bouchentouf SM; Kaoui HE; Bounaim A
Pan Afr Med J; 2021; 40():243. PubMed ID: 35233263
[TBL] [Abstract][Full Text] [Related]
7. [A Case of Synchronous Multiple Colorectal Cancer with Rectal Neuroendocrine Tumor and Ascending Colon Cancer].
Shigehara F; Kobayashi H; Yamane M; Koizumi A; Hattori Y; Mori S; Igarashi Y; Takashima J; Yamazaki K; Miura F; Taniguchi K; Matsutan N
Gan To Kagaku Ryoho; 2021 Dec; 48(13):1780-1782. PubMed ID: 35046328
[TBL] [Abstract][Full Text] [Related]
8. Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms?
Merola E; Rinke A; Partelli S; Gress TM; Andreasi V; Kollár A; Perren A; Christ E; Panzuto F; Pascher A; Jann H; Arsenic R; Cremer B; Kaemmerer D; Kump P; Lipp RW; Agaimy A; Wiedenmann B; Falconi M; Pavel ME
Ann Surg Oncol; 2020 May; 27(5):1348-1355. PubMed ID: 31720931
[TBL] [Abstract][Full Text] [Related]
9. Genomics of High-Grade Neuroendocrine Neoplasms: Well-Differentiated Neuroendocrine Tumor with High-Grade Features (G3 NET) and Neuroendocrine Carcinomas (NEC) of Various Anatomic Sites.
Uccella S; La Rosa S; Metovic J; Marchiori D; Scoazec JY; Volante M; Mete O; Papotti M
Endocr Pathol; 2021 Mar; 32(1):192-210. PubMed ID: 33433884
[TBL] [Abstract][Full Text] [Related]
10. Grade 3 well-differentiated neuroendocrine tumor of the rectum: a case report.
Ito M; Hirano Y; Isii T; Kondo H; Wang L; Asari M; Obara N; Yamaguchi S
Surg Case Rep; 2020 Jun; 6(1):130. PubMed ID: 32533349
[TBL] [Abstract][Full Text] [Related]
11. Unmet Needs in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (WHO G3).
Sorbye H; Baudin E; Borbath I; Caplin M; Chen J; Cwikla JB; Frilling A; Grossman A; Kaltsas G; Scarpa A; Welin S; Garcia-Carbonero R;
Neuroendocrinology; 2019; 108(1):54-62. PubMed ID: 30153658
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R
Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208
[TBL] [Abstract][Full Text] [Related]
13. Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine Carcinomas.
Tang LH; Untch BR; Reidy DL; O'Reilly E; Dhall D; Jih L; Basturk O; Allen PJ; Klimstra DS
Clin Cancer Res; 2016 Feb; 22(4):1011-7. PubMed ID: 26482044
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum alpha-fetoprotein in poorly differentiated adenocarcinoma with neuroendocrine differentiation of the ascending colon: a case report.
Lin HH; Chang CC; Yang SH; Chang SC; Chen WS; Liang WY; Lin JK; Jiang JK
World J Surg Oncol; 2016 Mar; 14():84. PubMed ID: 26976278
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic analysis and clinicopathological features of 20 patients with appendiceal neuroendocrine neoplasms].
Mao W; Lyu Y; Pu N; Li J; Xin B; Chen W; Jin D; Lou W; Xu X
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 May; 21(5):564-568. PubMed ID: 29774940
[TBL] [Abstract][Full Text] [Related]
16. Gastroenteropancreatic High-Grade Neuroendocrine Neoplasms: Histology and Molecular Analysis, Two Sides of the Same Coin.
Busico A; Maisonneuve P; Prinzi N; Pusceddu S; Centonze G; Garzone G; Pellegrinelli A; Giacomelli L; Mangogna A; Paolino C; Belfiore A; Kankava K; Perrone F; Tamborini E; Pruneri G; Fazio N; Milione M
Neuroendocrinology; 2020; 110(7-8):616-629. PubMed ID: 31557757
[TBL] [Abstract][Full Text] [Related]
17. Single institutional experience on primary neuroendocrine neoplasms of the kidney: a rare distinct entity.
Amin M; Trikalinos N; Chatterjee D
Hum Pathol; 2021 Aug; 114():36-43. PubMed ID: 33891968
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD133 in neuroendocrine neoplasms of the digestive tract: a detailed immunohistochemical analysis.
Mia-Jan K; Munkhdelger J; Lee MR; Ji SY; Kang TY; Choi E; Cho MY
Tohoku J Exp Med; 2013 Apr; 229(4):301-9. PubMed ID: 23615455
[TBL] [Abstract][Full Text] [Related]
19. [Consensus and controversy on subtype classification of gastric neuroendocrine neoplasms].
Tan H
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):977-981. PubMed ID: 28900986
[TBL] [Abstract][Full Text] [Related]
20. A Consensus-Developed Morphological Re-Evaluation of 196 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Its Clinical Correlations.
Elvebakken H; Perren A; Scoazec JY; Tang LH; Federspiel B; Klimstra DS; Vestermark LW; Ali AS; Zlobec I; Myklebust TÅ; Hjortland GO; Langer SW; Gronbaek H; Knigge U; Tiensuu Janson E; Sorbye H
Neuroendocrinology; 2021; 111(9):883-894. PubMed ID: 33002892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
